Amanda Doyle appointed as NHS England director of primary and community care


Share post:

Dr Amanda Doyle has been appointed as NHS England as director of primary and community care.

Prior to her new role, Amanda had joined NHS England and NHS Improvement as North West Regional Director on 2 August 2021 and previously she was the Chief Clinical Officer for West Lancashire Clinical Commissioning Group (CCG), Blackpool CCG and Fylde and Wyre CCG.

Amanda was also the Integrated Care System Lead for Lancashire and South Cumbria, leading a large health and care transformation programme across the patch.

She has been a GP for more than 20 years, practicing in a large practice in a deprived area of Blackpool, which, in addition to primary medical services, provides a range of urgent care services for patients across the Fylde Coast.

Amanda was the Co-Chair of NHS Clinical Commissioners from 2013 to 2018.

She was Senior Responsible Officer for the primary care component of the Long Term Plan and was involved in the leadership of the health inequalities, prevention and personalization elements.

Responding to Dr Amanda Doyle’s appointment to NHS England as director of primary and community care, Matthew Taylor, chief executive of the NHS Confederation, said: “It is hugely encouraging that Dr Amanda Doyle, as a highly experienced GP, former CCG accountable officer and ICS leader, has been appointed as the new director of primary and community care at NHS England.

“Amanda’s vast experience positions her well to take forward what good integrated out-of-hospital care can look like. Also, we are moments away from Dr Claire Fuller’s landmark review that will set out how primary care can be best supported by the system, and so Amanda will have an important responsibility in progressing these recommendations on behalf of the sector.

“Amanda is a friend of the NHS Confederation’s, not least from when she was chair of our NHS Clinical Commissioners network. On behalf of health leaders across the system, we would like to congratulate Amanda on her appointment and we look forward to building on this relationship in her new role.”



Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...